peptidyl-trna

Spectinomycin dihydrochloride (Actinospectacin) is an antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.

Spectinomycin dihydrochloride pentahydrate (Spectogard) is an antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.

Lumifusidic Acid, a derivative of Fusidic Acid, is classified as a static antibiotic. Fusidic Acid inhibits protein synthesis in prokaryotes by blocking the ribosome-dependent activity of the G factor and the translocation of peptidyl-tRNA. Additionally, this compound can inhibit the lytic effect of nitric oxide on islet cells.

Capreomycin IA is a bactericidal agent that targets bacterial ribosomes, with its antibacterial activity primarily limited to mycobacteria. It inhibits protein synthesis by blocking the translocation of peptidyl-tRNA from the A-site to the P-site. Capreomycin IA is active against Mycobacterium tuberculosis and is utilized in research related to tuberculosis.

Clindamycin (Sobelin) dissociates peptidyl-tRNA from the bacterial ribosome, thereby disrupting bacterial protein synthesis. Clindamycin is a semisynthetic broad-spectrum antibiotic produced by chemical modification of the parent compound lincomycin.

Diethanolamine Fusidate is a bacteriostatic antibiotic with similar activity and better absorption after oral administration (in animals) than the sodium salt of Fusidic Acid. This product inhibits protein synthesis in prokaryotes by inhibiting the ribosome-dependent activity of G factor and translocation of peptidyl-tRNA.

Clindamycin-13C-D3 the 13C and deuterated compound of Clindamycin (T6447). Clindamycin has a CAS number of 18323-44-9. Clindamycin dissociates peptidyl-tRNA from the bacterial ribosome, thereby disrupting bacterial protein synthesis. Clindamycin is a semisynthetic broad-spectrum antibiotic produced by chemical modification of the parent compound lincomycin.